Why MedTech’s Most Critical Leadership Gap Is Getting Harder to Ignore
Engineering expertise and regulatory accountability almost never sit in the same person. As of February 2, 2026, FDA’s new inspection framework follows risk across the full product lifecycle—and that gap is no longer a background risk. It is a current exposure.
Simultaneous Challenges, Not Sequential Problem The Operating Reality of a Complex Multi-Program Executive in Medical Device Development
A regulatory attorney session, an international design review, a 483 remediation call, a hospital executive update, a QMS compliance deadline, and a CFO budget meeting—in the same week. Not exceptional. Most weeks. Here’s what actually makes it sustainable.
Proton Therapy as a Case Study in Systems IntegrationEngineering, Regulatory, and Operations at the Frontier
A particle accelerator. A 100-ton rotating gantry. 20 major assemblies from across the globe. 50+ international safety standards as design inputs. One FDA 510(k) submission. This is what real systems integration complexity looks like—and what it teaches about every program that follows.
Safety-Rated PLCs: The Missing Link Between Medical Device Innovation and Regulatory Excellence
Chemical plants, oil refineries, and aerospace adopted safety-rated PLCs decades ago. Medical device manufacturers are still using safety relays. With FDA’s QMSR and mandatory IEC 62443 cybersecurity requirements now in effect, that gap is a liability—not a choice.